GLP-Certified Viral Testing And Clearance Services

Ensuring viral safety is a critical component of biologics development, particularly for products derived from human or animal cell lines. Robust testing strategies are required to detect, quantify, and eliminate potential viral contaminants while meeting stringent global regulatory expectations.

Modern viral safety programs integrate a range of validated in vitro and molecular assays designed to identify adventitious agents, retroviruses, and other potential risks at multiple stages of production, from cell bank characterization to final product evaluation. These studies often align with internationally recognized guidelines, enabling acceptance across regulatory bodies and facilitating smoother submissions. In addition to technical rigor, successful viral testing frameworks prioritize flexibility, scalability, and rapid turnaround, supporting both early-phase clinical timelines and large-scale manufacturing.

By combining scientific expertise with standardized processes and advanced detection technologies, these services help ensure product integrity, safeguard patient health, and maintain compliance throughout the development lifecycle of biopharmaceutical products.